February 06,2008

Sen. Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA

Please view the printer-friendly version of Senator Grassley’s letter regarding the FDA, a pharmaceutical drug maker and a safety officer at the FDA.

Next Article Previous Article

Recent News

04/17/24 Crapo Statement at Hearing on the President’s 2024 Trade Policy Agenda
04/16/24 Crapo Statement at Hearing on IRS FY 2025 Budget and 2024 Filing Season
04/11/24 Crapo Statement at Hearing on Medicare Clinician Payment Improvements
03/21/24 Crapo Blasts President’s Budget: “Higher Taxes for the Majority to Support Government Subsidies for the Few”
03/21/24 Crapo Statement at Hearing on President’s FY 2025 Budget